Tampa General Hospital is the first in the Southeast to implement the MeMed BV host-response test in its emergency workflow, reporting a 33% reduction in cefepime use and 13% fewer hospitalizations, according to hospital-led research.
The August/September 2022 Tech Guide that appears in CLP features a wide-range of products from top laboratory providers.
In screening for sepsis in newborns, there is a need to develop sensitive, and integrated diagnostic strategies to enhance detection.
The handheld device works much like blood sugar monitors and can be used at home to measure a biomarker for cancer.
Read More
The Allegro and its StatStrip-A companion meter now provide 18 tests to help physicians make therapeutic decisions and adjustments at the point of care.
Read More
The FDA CLIA-waived handheld analyzer reliably and efficiently delivers results within just 5 to 10 seconds, and it can be used in point-of-care (POC) and certificate of waiver settings, such as physicians’ offices, clinics, and other nontraditional laboratory locations.
Read More
The app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
Read More
SpeeDx and the QuantuMDx Group are collaborating with the Foundation for Innovative New Diagnostics to assess the feasibility of developing low-cost, point-of-care tests for common sexually transmitted infections.
Read More
The assay is intended to help stop the spread and transmission of carbapenem-producing organisms.
Read More
Quo-Lab meets strict international quality targets, confirming its fit for purpose in diabetes testing.
Read MoreThe study found that using POC tests as a replacement for laboratory tests resulted in earlier decisionmaking in approximately 75% of cases across three UK hospital sites.
Read More
POC testing is unlocking new markets for commercial IVDs, but reaching potential new customers can be a challenge.
Read MoreCinical laboratorians are likely to remain an important part of the process for selecting, adopting, managing, and performing POC testing.
Read More
This month’s issue features point-of-care assays and analyzers from such companies as BioFire Diagnostics, EKF Diagnostics, and Roche Diagnostics.
Read More
With connectivity, point-of-care testing is on the front line when it comes to diagnosing and managing chronic diseases.
Read MoreRelaymed’s secure, cloud-based service will connect Siemens POC instruments to physician-office electronic health record systems, reducing the potential for errors and revenue loss.
Read More
The device is the first of the company’s Alinity family of diagnostic instruments to launch.
Read More
The company has launched its next-generation wireless rapid diagnostic system for detection of group A Strep, influenza A and B, and respiratory syncytial virus.
Read More